Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002052113-25-001848·BIOMARIN PHARMACEUTICAL INC
Schedule 13G ownership disclosure
BioMarin Pharmaceutical Inc
Common Stock · CUSIP: 09061G101
Event date: 2025-03-31
- Filing-level shares
- 20,620,179.00
- Percent of class
- 10.8%
- BlackRock, Inc.
Shares: 20,620,179.00 · Class: 10.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-25-001848
- Form type
- SCHEDULE 13G/A
- Filer
- BIOMARIN PHARMACEUTICAL INC
- CIK
- CIK 1048477
- Filed
- Apr 29, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership